kras mutation and glutathion glynac Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients? Targeting mutated GTPase KRAS in
Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect Supplementing Glycine and N Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial PMC Mutant KRas Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions ScienceDirect Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





